Home > Healthcare > Medical Devices > Surgical Devices > Myomectomy Market

Myomectomy Market Trends

Report ID: GMI6678
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Myomectomy Market Trends

Minimally invasive myomectomy techniques have gained popularity due to several advantages over traditional open surgery. Patients undergoing minimally invasive myomectomy procedures typically experience shorter hospital stays and quicker recovery times compared to traditional open surgery. This is especially appealing to individuals desiring to return to their normal activities sooner. Thus, demand for minimally invasive myomectomy procedure is anticipated grow in upcoming years.

Furthermore, advances in medical technology have yielded sophisticated surgical devices and equipment for myomectomy, offering surgeons enhanced precision, visualization, and control during procedures. Moreover, this has translated into improved patient outcomes and reduced complications. Therefore, the widespread adoption of robotic-assisted systems and advanced laparoscopic tools has significantly boosted the effectiveness of myomectomy, further stimulating the growth of the market.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global myomectomy market was valued at USD 681 million in 2022 and is estimated to account for USD 1.6 billion by 2032.

The abdominal myomectomy segment held over 38% market share in the year 2022 and is anticipated to witness substantial growth through 2032 as myomectomy is the only permanent treatment for uterine fibroids, giving patients the chance to maintain fertility.

U.S. myomectomy market accounted for USD 265 million in 2022 and is predicted to witness substantial market growth over 2023-2032, due to the high prevalence of uterine fibroids.

Medtronic, Stryker Corporation, CONMED Corporation, INSIGHTEC, Cooper Surgical Inc., Hologic, Inc., Intuitive Surgical, Karl Storz, B. Braun Melsungen AG, and Minerva Surgical Inc, among others.